Ulrike Fasol1, Klaus Mross2, Annette Frost2, Martin Buechert1, Valerij Kiselev1, Juergen Hennig1
1MR Development & Application Center, University Medical Center Freiburg, Freiburg, Germany; 2Tumor Biology Center, Albert-Ludwigs-University Freiburg, Freiburg, Germany
Using the Apparent Diffusion Coefficient (ADC) as a biomarker for tumors under therapy is currently under investigation. In most studies contrast enhanced imaging is included in the protocol, which poses the problem of the influence of the contrast agent on the determination of ADC. Studies performed till now were mainly focused on measurements in the brain. We present results for the effect of contrast agent on the ADC measurements in normal liver tissue and metastasis at 1.5 T.